Last reviewed · How we verify

Iritis — Treatment Landscape & Competitive Intelligence

Iritis (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Iritis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Loteprednol Etabonate LOTEPREDNOL Bausch And Lomb 2020-01-01
Lotemax LOTEPREDNOL ETABONATE Bausch Health Corticosteroid Glucocorticoid receptor 1998-01-01
Flarex FLUOROMETHOLONE ACETATE Harrow Health Corticosteroid Glucocorticoid receptor 1986-01-01
Fml FLUOROMETHOLONE AbbVie Corticosteroid Glucocorticoid receptor 1972-01-01
Medrifar MEDRYSONE AbbVie Corticosteroid Glucocorticoid receptor 1969-01-01
Decadron dexamethasone Generic (originally Merck) Corticosteroid [EPC] Annexin A1, Interleukin-4, Androgen receptor 1958-10-30
Prelone prednisolone Generic (originally Schering) Glucocorticoid (corticosteroid) Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1 1955-01-01
Cortef hydrocortisone Generic (originally Merck/Upjohn) Corticosteroid [EPC] Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible 1952-01-01
Cortisol Cortisol University of Zurich Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible
Lotemax Lotemax Tufts Medical Center Glucocorticoid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. AbbVie · 2 drugs in Iritis
  2. Bausch And Lomb · 1 drug in Iritis
  3. Bausch Health · 1 drug in Iritis
  4. Generic (originally Merck) · 1 drug in Iritis
  5. Generic (originally Merck/Upjohn) · 1 drug in Iritis
  6. Generic (originally Schering) · 1 drug in Iritis
  7. Hannover Medical School · 1 drug in Iritis
  8. Harrow Health · 1 drug in Iritis
  9. Tufts Medical Center · 1 drug in Iritis
  10. · 1 drug in Iritis
  11. University of Zurich · 1 drug in Iritis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Iritis:

Cite this brief

Drug Landscape (2026). Iritis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/iritis. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing